Health News Roundup: China gives conditional OK to its first self-developed Alzheimer's drug

Following is a summary of current health news briefs.

China gives conditional OK to its first self-developed Alzheimer's drug

China has granted conditional approval to its first self-developed treatment for Alzheimer's disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.

Also Read: Science News Roundup: U.S. astronauts embark on the first all-female spacewalk; China's next commercial rockets to make test flights in 2020, 2021